Cipcommunity

Beximco Pharma

Beximco Pharma

Beximco Pharma Submitted to: Husna Ara Lecturer, Department of Business Administration East West University Submitted by: Group: 3 Name| ID| Signature| Shajia Afrin| 2011-2-30-120| | Shahena Akter| 2011-2-30-125| | Sadia Akter Moury| 2011-2-30-119| | Shoha Afrin| 2011-2-30-123| | Lutfun Nahar Diba | 2011-2-40-176| | Date of Submission: 12-07-2011 13 July, 2011 To, HUSNA ARA Lecturer, Department of Business Administration, East West University, Dhaka. Subject: Submission of project report (BUS 101) Dear Madam, It is my great pleasure to submit the report on Beximco Pharmaceuticals Ltd. hich is a part of BBA program to you for your kind consideration. Encouraged by your mentoring, I went beyond typical “observe-describe” manner in preparing this report. My endeavor was to attain a thorough understanding of the analytical techniques and skill necessary to identify and exploit strategies successfully. Within the time limit and our knowledge & capability, we paid sincere efforts to study related materials, documents, observed operations performed in Square Pharmaceuticals Ltd and examine relevant records for preparation of the report.

But there may exist some mistakes and errors due to various limitations. Therefore, we beg your kindness in advance. I’ll be available anytime if you confront any difficulty to translate any aspect of this report. You are requested to accept this report and oblige me thereby. Sincerely yours Shajia Afrin Shahena Akter Sadia Akter Moury Shoha Afrin Lutfun Nahar Diba ACKNOWLEDGEMENT In preparing this report a considerable thinking and informational input from various sources were involved.

I express my sincere gratitude to everyone who contributed towards making this study and preparing the possible. Major contributions were received from the sum of officials of Square Pharmaceuticals Ltd. I would like to thank Mr. You us Ali, Manager of Human Resources and Abdul Kader Jilani, executive of Human resources, for their Support and co-operation. In spite of having very busy schedule, they made sure in every way that we require. We have benefited from the help of some websites and research paper where we found some valuable information for our project work.

Our sincere gratitude goes to our project supervisor Md. Asifuzzaman for encouraging me to such a study to fulfill my project requirement. He gave all time and attention, which I needed to complete my study and compile my report in as much orderly was as possible. Last but not the least; I would like to thank my friends and family, for support and help me to complete the report. The company is the largest exporter of pharmaceuticals from Bangladesh and the only company to receive National Export Trophy (Gold), the highest ational accolade for export, for record three times. BPL has a global footprint in more than 45 countries across four continents and currently in the process of entering the emerging markets of CIS with increasing focus on regulated markets like EU and USA. Besides the retail outlets, Beximco Pharma’s products are being supplied to renowned hospitals and institutions like Raffles Hospital and K K Women & Children Hospital in Singapore, MEDS and Kenyatta National Hospital (KNH) in Kenya, Jinnah Hospital, and Agha Khan Hospital in Pakistan.

In this report we have tried to find out some aspects relating to Beximco Pharma taken by activities taken by a company. For this reason some related theories and some existing literatures are reviewed. Also it involves some basic information and history Beximco Pharma Ltd. Finally the report contains some necessary recommendations for this company to improve their product according to the findings and analysis. Table of Content Chapter One: Title page Later of transmittal Acknowledgement Executive Summary Chapter Two: 7. 1: Introduction 7. : Beginning of Pharmaceutical Business in Bangladesh 7. 3: Company Background Chapter Three: 7. 4; Vision, mission, objectives 7. 5: Product 7. 6: Price Chapter Four: 7. 7: Distribution 7. 8: Promotion Chapter Five: Organizational Structure and Divisions of SCB 7. 9: Management & its functions 7. 10: Human Resource practices and recruitment process 7. 11: competitors 7. 12: Strengths and weakness Conclusion Recommendations References (7. 1) Introduction Beximco Pharmaceuticals Ltd. Also known as Beximco pharma is a pharmaceutical company in Bangladesh.

It is part of the Beximco group of companies. (7. 2) Beginning of Pharmaceutical Business in Bangladesh. Beximco pharma started operations in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of USA. It has now grown to become leading pharmaceutical company in Bangladesh, and it supplies more than 10% of country’s total medicinal needs. (7. 3) Company background Company Background Beximco Pharmaceuticals Ltd (BPL) is a leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh.

The company is the largest exporter of pharmaceuticals in the country and its state-of-the-art manufacturing facilities are certified by global regulatory bodies of Australia, Gulf nations, Brazil, among others. The company is consistently building upon its portfolio and currently producing more than 400 products in different dosage forms covering broader therapeutic categories which include antibiotics, antihypertensive, ant diabetics, antireretrovirals, anti asthma inhalers etc, among many others.

With decades of contract manufacturing experience with global MNCs, skilled manpower and proven formulation capabilities, the company has been building a visible and growing presence across the continents offering high quality generics at the most affordable cost. Ensuring access to quality medicines is the powerful aspiration that motivates more than 2,500 employees of the organization, and each of them is guided by the same moral and social responsibilities the company values most. Year of Establishment: 1976 Country of Incorporation :: Bangladesh Commercial Production :: 1980

Status :: Public Limited Company Business Lines :: Manufacturing and marketing of pharmaceutical Finished Formulation Products, Large Volume Parenterals and Active Pharmaceutical Ingredients (APIs) Main Country of operation :: Bangladesh Corporate Headquarter & Registered Address :: 17 Dhanmondi R/A, Road No. 2, Dhaka- 1205, Bangladesh Phone: +880-2-8611891 (5 lines) Fax: +880-2-8613470 Email: [email protected] net This e-mail address is being protected from spambots. You need JavaScript enabled to view it Operational Headquarter: 19 Dhanmondi R/A, Road No. 7, Dhaka- 1205, Bangladesh

Phone: +880-2-8619151 (5 lines), +880-2-8619091 (5 lines) Fax: +880-2-8613888 Email: [email protected] net This e-mail address is being protected from spambots. You need JavaScript enabled to view it Website: www. beximcopharma. com Overseas Offices & Associates :: Australia, Bhutan, Cambodia, Chile, Ghana, Hong Kong, Indonesia, Jordan, Kenya, Kuwait, Malaysia, Myanmar, Nepal, Pakistan, Philippines,Saudi Arabia, Singapore, Sri Lanka, Vietnam and Yemen Authorized Capital (Taka) :: 90,000 million Paid-up Capital (Taka) :: 2,098 million Number of Shareholders :: Around 68,000

Stock Exchange Listings :: Dhaka and Chittagong Stock Exchanges of Bangladesh and AIM of London Stock Exchange Number of Employees :: 2,507 TIDM: (Tradable Instrument Display Mnemonic) :: BX (7. 4). Vision, Mission objective: We view business as a means to the material and social wellbeing of the investors, employees and the society at large, leading to accretion of wealth through financial and moral gains as a part of the process of the human civilization. Our mission is to produce and provide quality and innovative healthcare relief for people, maintain stringently ethical tandard in business operation also ensuring benefit to the shareholders, stakeholders and the society at large. Our objectives are to conduct transparent business operation based on market mechanism within the legal and social frame work with aims to attain the mission reflected by our vision. (7. 5) Product [Variety / Packages / Service] Our People Working at Beximco Pharma is like being part of an extended family. Our culture, our communication channels and people centered management policies make us one of the best organizations to work in.

Our congenial work environment and open channel communication fosters creativity, responsibility and a sense of ownership in every employee. What we have achieved for the last 27 years (since our inception in 1980) is through the efforts, innovations and abilities of our employees. We believe that our people are the life force that drives BPL to achieve what it does best, produce & market quality medicines to serve the needs each and every individual, every locality, ethnicity, and community of Bangladesh and the world as a whole. (7. 6). Price [Annual Report]

Notification No. SEC/CMRRCD/2008-183/Admin/03-34 dated September 27, 2009. ASSETS Non-Current Assets Property, Plant and Equipment – Carrying Value Intangible Assets Investment in Shares Current Assets Inventories Spares & Supplies Accounts Receivable Loans, Advances and Deposits Short Term Investment Cash and Cash Equivalents TOTAL ASSETS EQUITY AND LIABILITIES Shareholders’ Equity Issued Share Capital Share Premium Excess of Issue Price over Face Value of GDRs Capital Reserve on Merger Revaluation Surplus Retained Earnings Non-Current Liabilities

Long Term Borrowings-Net off Current Maturity (Secured) Liability for Gratuity ; WPPF Deferred Tax Liability Current Liabilities and Provisions Short Term Borrowings Long Term Borrowing-Current Maturity Creditors and Other Payables Accrued Expenses Dividend Payable TOTAL EQUITY AND LIABILITIES 15,222,716 15,149,270 67,147 6,299 6,458,435 2,084,166 292,957 887,309 866,709 889,483 1,437,811 21,681,151 16,172,452 2,098,065 5,269,475 1,689,637 294,951 1,474,471 5,345,853 2,968,640 1,920,346 346,890 701,404 2,540,059 1,651,895 330,998 441,409 114,322 1,435 21,681,151

Beximco Pharmaceuticals Ltd. Statement of Financial Position (Un-Audited) As at 31 March, 2011 Amount in Thousand Taka 15,180,732 15,123,306 51,127 6,299 6,191,667 1,983,809 276,520 821,356 779,130 859,404 1,471,448 21,372,399 15,974,087 2,098,065 5,269,475 1,689,637 294,951 1,534,646 5,087,313 2,885,156 1,902,151 335,886 647,119 2,513,156 1,639,961 348,860 432,315 90,512 21,372,399 As at 31 March 2011 As at 31 December 2010 Nazmul Hassan Managing Director Ali Nawaz Chief Financial Officer (7. 7) Distribution: Benches Corporate Headquarter ; Registered Address: 17 Dhanmondi R/A, Road No. , Dhaka- 1205, Bangladesh Phone: +880-2-8611891 (5 lines) Fax: +880-2-8613470 Email: [email protected] net Operational Headquarter: 19 Dhanmondi R/A, Road No. 7, Dhaka- 1205, Bangladesh (7. 88) Promotion [Tools, Media] Beximco Pharmaceuticals Ltd (BPL) is a leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh. The company is the largest exporter of pharmaceuticals in the country and its state-of-the-art manufacturing facilities are certified by global regulatory bodies of Australia, Gulf nations, Brazil, among others.

The company is consistently building upon its portfolio and currently producing more than 400 products in different dosage forms covering broader therapeutic categories which include antibiotics, antihypertensives, antidiabetics, antireretrovirals, anti asthma inhalers etc, among many others. With decades of contract manufacturing experience with global MNCs, skilled manpower and proven formulation capabilities, the company has been building a visible and growing presence across the continents offering high quality generics at the most affordable cost.

Ensuring access to quality medicines is the powerful aspiration that motivates more than 2,500 employees of the organization, and each of them is guided by the same moral and social responsibilities the company values most. Manufacturing Facilities Located at Tongi, near the capital city Dhaka, BPL’s manufacturing site is spread over an area of 20 acres which houses a number of self contained production units including oral solids, metered dose inhalers, intravenous fluids, liquids, ointments, creams, suppositories, ophthalmic drops, injectables, nebulizer solutions etc.

The bulk drug unit for producing paracetamol is also located within this site. Company’s penicillin API and formulation units are situated at Kaliakoir, a few kms from the main site. The plant and machinery throughout the site have been designed by and procured mostly from renowned European companies. Beximco Pharma has its own utility infrastructure to ensure adequate generation and distribution of purified water at all times. The installed capacity of power generation is 8 MW. There is also liquid nitrogen generation facility on site. (7. 9) Management and its faction [Board of Directors]

BEXIMCO Group is the largest private sector industrial conglomerate in Bangladesh engaged in diverse business areas. BEXIMCO comprises of five publicly listed companies and sixteen private companies. The Group turnover in 2008 was BDT 18. 5 billion. BEXIMCO employs 35,000 people and has 230,000 shareholders. BEXIMCO’s shares constitute 3. 24% of the market capitalization of DSE. (7. 10) Human recourse practice and Recruitment process: A responsibility for recruitment usually belongs to the HR department.

This department Works to find and attract capable applicants. Job description and speciation provide the Needed information upon which the recruitment process starts. The functions of the Recruitment office of BPL is given below: 1. Need Assessment 2. Defining the position description 3. Checking the recruiting options 4. Advertisement 5. Screening and Short – listing Applications 6. Written test 7. Selection interview (3 – tier) 8. Employment decision (Application Bank) 9. Pre- employment medical check-up 10. Offer letter 11. Orientation / Induction 12. Placement 13. Follow –up (7. 11) Competitors (7. 12) Strengths and Weakness:

Beximco Pharma product is available in the market. People can buy their product in a short time. Conclusion: Beximco Pharma was born out of a vision to provide proper medicine for proper illness with there technology and their experience it is well-known all over the world. Recommendation: Beximco pharmacy’s product should be increased. REFERENCES 1. Husna Ara Lecturer, Department of Business Administration East West University 2. http://www. Beximcopharmaceutical. com 3. http://www. Beximcopharmaceutical . graduates 4. Cash Management Folder of Beximco pharmaceutical 5. Price Research by pharmacy 6. Creasent pharmacy